BioHealth News Archive

FounderTrac closes out with demo day in Annapolis – Technical.ly Baltimore

FounderTrac closes out with demo day in Annapolis – Technical.ly Baltimore

At the Loews Annapolis Hotel on Tuesday night, ten founders took the stage. They were gathered before a full audience of tech community members…

Read More
How a local scientist became an accidental entrepreneur – FederalNewsRadio.com

How a local scientist became an accidental entrepreneur – FederalNewsRadio.com

Contrary to popular belief, the D.C. region can be a dynamic place to start a life science business. Many things that we are now…

Read More
Just 3 Weeks Away! Is your Intellectual Property protected?

Just 3 Weeks Away! Is your Intellectual Property protected?

Safeguard Your Intellectual Property Internationally & in the U.S. Learn about IP and how to protect it Online, while Exporting and at Trade Shows…

Read More
Sign up to Host Summer RISE by April 13 – Worksource Montgomery

Sign up to Host Summer RISE by April 13 – Worksource Montgomery

It is our pleasure to host the Summer RISE program again this year. We had some amazing students last year and we look forward…

Read More
WellDoc Announces Providence Health & Services’ Implementation of BlueStar® Digital Therapeutic in a Pilot Program for Individuals with Type 2 Diabetes

WellDoc Announces Providence Health & Services’ Implementation of BlueStar® Digital Therapeutic in a Pilot Program for Individuals with Type 2 Diabetes

Today, WellDoc® announced a pilot program in the Providence Health & Services Oregon/SW Washington Region to examine the use of WellDoc’s BlueStar®, an FDA-cleared,…

Read More
Gliknik Announces Issuance of U.S. Patent for Use of Recombinant IVIG Mimetics

Gliknik Announces Issuance of U.S. Patent for Use of Recombinant IVIG Mimetics

Gliknik Inc. today announced that the U.S. Patent & Trademark Office (PTO) has issued U.S. Patent 9,926,362, which claims methods of using compounds that…

Read More
GE Sheds Health IT Assets for $1B, Doubles Down on A.I. and Devices – Xconomy

GE Sheds Health IT Assets for $1B, Doubles Down on A.I. and Devices – Xconomy

General Electric is selling a chunk of its healthcare IT business to New York private equity firm Veritas Capital for $1.05 billion in cash,…

Read More
Compugen signs cancer drug licensing deal worth up to $200m

Compugen signs cancer drug licensing deal worth up to $200m

MedImmune, the R&D arm of AstraZeneca, will make an immediate payment of $10 million to the Israeli cancer immunotherapy company. Israeli cancer immunotherapy company…

Read More
2018 FNIH Lurie Prize in Biomedical Sciences Winner Discovered How DNA Stimulates Immune Response

2018 FNIH Lurie Prize in Biomedical Sciences Winner Discovered How DNA Stimulates Immune Response

The Foundation for the National Institutes of Health (FNIH) is delighted to recognize Zhijian “James” Chen, Ph.D., with the 2018 Lurie Prize in Biomedical…

Read More
Senseonics Announces Favorable Outcome of FDA Advisory Committee on the Eversense System – Senseonics

Senseonics Announces Favorable Outcome of FDA Advisory Committee on the Eversense System – Senseonics

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of Eversense®, a long-term, implantable continuous glucose monitoring…

Read More
WeWork to Open First Maryland Location on University of Maryland Campus – UMD Right Now

WeWork to Open First Maryland Location on University of Maryland Campus – UMD Right Now

Adding to the growing momentum in Prince George’s County, WeWork, a global leader in coworking with more than 200 locations in 21 countries around…

Read More
Altimmune Announces Positive Data From Its Phase 2a Study of NasoVAX Intranasal Influenza Vaccine and Provides an Update on Its Phase 1b Study of HepTcell Targeted Immunotherapy in Chronic Hepatitis B Infection | Altimmune, Inc.

Altimmune Announces Positive Data From Its Phase 2a Study of NasoVAX Intranasal Influenza Vaccine and Provides an Update on Its Phase 1b Study of HepTcell Targeted Immunotherapy in Chronic Hepatitis B Infection | Altimmune, Inc.

Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company, today announced positive data from its Phase 2a study of NasoVAX intranasal influenza vaccine and provided an…

Read More
JHU Launches New Concentration in Regenerative and Stem Cell Technologies – News – Johns Hopkins University Montgomery County Campus

JHU Launches New Concentration in Regenerative and Stem Cell Technologies – News – Johns Hopkins University Montgomery County Campus

Johns Hopkins University is launching a new concentration in Regenerative and Stem Cell Technologies within the Master of Science in Biotechnology. Students will become…

Read More
WeWork goes where future entrepreneurs are in College Park | WTOP

WeWork goes where future entrepreneurs are in College Park | WTOP

Co-working space company WeWork is opening its first location in Maryland and it’s where the future of business lives: on a college campus. WeWork…

Read More
Funding Early Stage Companies: Guidance from the Deerfield and NextCure

Funding Early Stage Companies: Guidance from the Deerfield and NextCure

When: Thursday, April 19, 2018 4:00 - 7:00 PM EST Where: Johns Hopkins Technology Ventures 1812 Ashland Avenue Baltimore, MD 21205 Deerfield Management is…

Read More